Business

MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and Africa

Exclusive agreement with Bayer to evaluate MustGrow's technologies to determine commercial po...

articleMustgrow Biologics Corp.January 21, 20223/company/mustgrow-biologics-corp/news/mustgrow-and-bayer-sign-exclusive-agreement-to-develop-sustainable-organic-biologicals-in-europe-asia-pacific-middle-east-and-africa
MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and Africa

About this update from Mustgrow Biologics Corp.

[{"type":"text","content":"MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and AfricaExclusive agreement with Bayer to evaluate MustGrow's technologies to determine commercial potential.Bayer has the option to acquire exclusive rights to MustGrow's technologies for preplant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes including sprout inhibition in the regions of Europe, Asia Pacific, Middle East and Africa. Bayer will fund and drive all laboratory, field development, regulatory work and market development.Saskatoon, Saskatchewan--(Newsfile Corp. - January 21, 2022) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (\"MustGrow\") and Bayer have signed an Exclusive Agreement to evaluate MustGrow's biological technologies to determine efficacy and commercial potential in key agricultural regions. Sustainable innovations and green technologies are necessary to ensure agricultural production continues to address food safety and security as well as soil health. This agreement between Bayer and MustGrow further demonstrates the importance of innovation in sustainable technologies in agricultural regions around the world.MustGrow has granted Bayer the right to use MustGrow's intellectual property for testing purposes and the option to acquire exclusive rights to MustGrow's technologies for preplant soil fumigation, bioherbicide applications, and postharvest food preservation of potatoes, including sprout inhibition in the regions of Europe, Asia Pacific, Middle East and Africa. Under the agreement, Bayer will fund and drive all laboratory, field development, regulatory work and market development necessary for commercialization. MustGrow continues to conduct field trials, R&D and regulatory development concurrently in other regions, collaborating with numerous agriculture, chemical products, and consumer food companies. MustGrow's technology pipeline is focused on remarkably safe, effective, organic plant-based biopesticides that harness the mustard seed's natural defense mechanism to treat diseases, pests and weeds. MustGrow's technology has shown consistent efficacy in many regions of North and South America, in multiple crops, covering many pests, over multiple years. \"We are thrilled to accelerate the development and und...

More updates from Mustgrow Biologics Corp.